High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities-Reference-Cited by-同舟云学术

High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities

Published:2015-06-08 Issue:9 Volume:50 Page:1201-1205
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Passweg J R, ,Schanz U,Chalandon Y,Güngör T,Baldomero H,Heim D,Nair G,Medinger M,Masouridi-Levrat S,de Faveri G N,Tiercy J-M

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2015129.pdf

Reference31 articles.

1. Petersdorf EW . Optimal HLA matching in haematopoietic stem cell transplantation. Curr Opin Immunol 2008; 20: 588–593.

2. Tiercy J-M, Nicoloso de Faveri G, Passweg J, Schanz U, Seger R, Chalandon Y et al. The probability to identify a 10/10 HLA allele-matched unrelated donor is highly predictable. Bone Marrow Transplant 2007; 40: 515–520.

3. Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. New Engl J Med 2010; 363: 2091–2101.

4. Gratwohl A, Baldomero H, Schwendener A, Rocha V, Apperley J, Frauendorfer K et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009; 43: 275–291.

5. Hambach L, Spierings E, Goulmy E . Risk assessment in hematopoietic stem cell transplantation: minor histocompatibility antigens. Best Pract Res Clin Haematol 2007; 20: 171–187.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An intermediate‐sized donor registry experience: HLA barriers in matching procedures;HLA;2024-01

2. Choix d’un donneur non apparenté en vue d’une allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire;Bulletin du Cancer;2023-09

3. Immunoserologic and hemotherapy considerations in patients undergoing hematopoietic progenitor cell transplantation;Annals of Blood;2022-04

4. Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT;Bone Marrow Transplantation;2020-10-02

5. A comparison of post-transplantation cyclophosphamide versus antithymocyte-globulin in patients with hematological malignancies undergoing HLA-matched unrelated donor transplantation;Medicine;2020-08-21